Cover Image

The interplay of EMT and stemness driving malignant transformation of Oral Submucous Fibrosis

Background: Oral submucous fibrosis (OSF) is a persistent oral mucosal condition that carries an elevated risk of undergoing malignant transformation. Our objective was to elucidate the involvement of epithelial-to-mesenchymal transition (EMT) in OSF and its progression to malignancy by studying a p...

Full description

Saved in:

Bibliographic Details
Main Authors:	Smitha Sammith Shetty (Author), Mohit Sharma (Author), Kanaka Sai Ram Padam (Author), Adarsh Kudva (Author), Pratik Patel (Author), Raghu Radhakrishnan (Author)
Format:	Book
Published:	Elsevier, 2024-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Myofibroblasts persist through immune privilege mechanisms to mediate oral submucous fibrosis: Uncovering the pathogenesis
by: Mohit Sharma, et al.
Published: (2024)

Signaling pathways promoting epithelial mesenchymal transition in oral submucous fibrosis and oral squamous cell carcinoma
by: Smitha Sammith Shetty, et al.
Published: (2020)

The Antifibrotic and the Anticarcinogenic Activity of Capsaicin in Hot Chili Pepper in Relation to Oral Submucous Fibrosis
by: Zoufang Huang, et al.
Published: (2022)

Oral submucous fibrosis associated with malignancy
by: Gargi Chaudhuri, et al.
Published: (2014)

Interplay of EMT and CSC in Cancer and the Potential Therapeutic Strategies
by: Shihori Tanabe, et al.
Published: (2020)

Oral Submucous Fibrosis a Distressing Disease with Malignant Potential
by: Afroz N, et al.
Published: (2006)

Facial Atrophy in Oral Submucous Fibrosis: An Association or a Coincidence
by: Sameep S. Shetty, et al.
Published: (2016)

Low LINC02147 expression promotes the malignant progression of oral submucous fibrosis
by: Jun Chen, et al.
Published: (2022)

Oral submucous fibrosis turning into malignancy- A case report and review of literature
by: Shamimul Hasan, et al.
Published: (2011)

HIF - 1α as a marker of risk assessment for malignant transformation in oral submucous fibrosis: An immunohistochemical study
by: Kanika Sharma, et al.
Published: (2022)

Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis
by: Raffaele Strippoli, et al.
Published: (2016)

Correction to: Low LINC02147 expression promotes the malignant progression of oral submucous fibrosis
by: Jun Chen, et al.
Published: (2022)

Oral submucous fibrosis: an update
by: Wollina U, et al.
Published: (2015)

Conspicuous and frank dilated vascular spaces: A marker of malignant transformation in oral submucous fibrosis
by: Sachin C. Sarode, et al.
Published: (2021)

Quantitative Immunoexpression of EGFR in Oral Potentially Malignant Disorders: Oral Leukoplakia and Oral Submucous Fibrosis
by: Naga Jyothi Meka, et al.
Published: (2015)

Predicting the Malignant Transformation of Oral Submucous Fibrosis Using Quantitative Biomarkers p63 and CD31
by: Radhika Manoj Bavle, et al.
Published: (2020)

Neutral zone and oral submucous fibrosis
by: Shaista Afroz, et al.
Published: (2012)

Evaluation of cachexia in oral submucous fibrosis
by: Pooja Singh, et al.
Published: (2012)

Classification system for oral submucous fibrosis
by: Chandramani Bhagvan More, et al.
Published: (2012)

Pentoxifylline in patients with oral submucous fibrosis
by: Ashwini Deshpande, et al.
Published: (2015)

Medical management of oral submucous fibrosis
by: Vagish Kumar Laxman Shanbhag
Published: (2015)

Efficacy of spirulina as an antioxidant adjuvant to corticosteroid injection in management of oral submucous fibrosis
by: Prathima Shetty, et al.
Published: (2013)

Evaluation of Platelet Parameters in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma in a Background of Oral Submucous Fibrosis
by: Packiaraj Selvajothi Ranjitham, et al.
Published: (2024)

Effectiveness of Long Term Supervised and Assisted Physiotherapy in Postsurgery Oral Submucous Fibrosis Patients
by: S. Kale, et al.
Published: (2016)

Editorial: New Approaches to Tackle EMT and Fibrosis: From Epigenetics to Nanotechnology
by: Cecilia Battistelli, et al.
Published: (2021)

Assessment and comparison of p53 and p63 expression in oral epithelial dysplasia and squamous cell carcinoma
by: Smitha Sammith Shetty, et al.
Published: (2014)

Oral submucous fibrosis and its dermatological relation
by: Fareedi Mukram Ali, et al.
Published: (2014)

Role of immunological alterations in oral submucous fibrosis
by: Sarada Malempati, et al.
Published: (2019)

Efficacy of pentoxifylline in the management of oral submucous fibrosis
by: Santosh Patil, et al.
Published: (2014)

Proposed clinical definition for oral submucous fibrosis
by: Chandramani B. More, et al.
Published: (2019)

Effect of Oral Submucous Fibrosis on Jaw Dimensions
by: Aarati Panchbhai
Published: (2019)

Drug treatment for oral submucous fibrosis: an update
by: Xueru Chen, et al.
Published: (2023)

Salivary coagulopathy and immunoglobulins in oral submucous fibrosis
by: R Pinakapani, et al.
Published: (2009)

Haemoglobin levels in patients with Oral Submucous Fibrosis
by: Lavina Taneja, et al.
Published: (2007)

Oral submucous fibrosis: A demographic study
by: Satish Kumar
Published: (2016)

Oral Submucous Fibrosis - A changing scenario
by: Tinky Rose, et al.
Published: (2007)

Verrucous carcinoma in association with oral submucous fibrosis
by: C Pravda, et al.
Published: (2011)

Multimodal treatment options for oral submucous fibrosis
by: A Gnanam, et al.
Published: (2010)

Qualitative analysis of dermatoglyphics in oral submucous fibrosis
by: Parvathi Devi Munishwar, et al.
Published: (2015)

Potentially Significant Biomarkers in Oral Submucous Fibrosis
by: Haya Mohammad, et al.
Published: (2024)